HSC Section 8_April 2017

16. Silverstein H, Rowan PT, Olds MJ, et al. Inner ear perfusion and the role of round window patency. Am J Otol 1997;18:586–589. 17. Yoshioka M, Naganawa S, Sone M, et al. Individual differences in the per- meability of the round window: evaluating the movement of intratym- panic gadolinium into the inner ear. Otol Neurotol 2009;30:645–648. 18. Goycoolea MV, Lundman L. Round window membrane. Structure function and permeability: a review. Microsc Res Tech 1997;36:20–11. 19. Nakashima T, Naganawa S, Sugiura M, et al. Visualization of endolym- phatic hydrops in patients with Meniere’s disease. Laryngoscope 2007; 117:415–420. 20. Thai-Van H, Bounaix MJ, Fraysse B. Meniere’s disease: pathophysiology and treatment. Drugs 2001;61:1089–1102. 21. Imamura S, Nozawa I, Imamura M. Clinical observations on acute low- tone sensorineural hearing loss. Survey and analysis of 137 patients. Ann Otol Rhinol Laryngol 1997;106:746–750. 22. Shojaku H, Watanabe Y, Yagi T, et al. Changes in the characteristics of definite Meniere’s disease over time in Japan: a long-term survey by the Peripheral Vestibular Disorder Research Committee of Japan. Acta Oto- laryngol 2009;129:155–160. 23. Perez R, Chen JM, Nedzelski JM. The status of the contralateral ear in established unilateral Meniere’s disease. Laryngoscope 2004;114:1373– 1376. 24. Navi S, Parnes LS. Bilateral Meniere’s disease. Curr Opin Otolaryngol Head Neck Surg 2009;17:356–362. 25. Tsuji K, Velazquez-Villaserior L, Rauch SD, et al. Temporal bone studies of the human peripheral vestibular system. Meniere’s disease. Ann Otol Rhinol Laryngol Suppl 2000;181:26–31. 26. Yazawa Y, Kitahara M. Bilateral endolymphatic hydrops in Meniere’s dis- ease: review of temporal bone autopsies. Ann Otol Rhinol Laryngol 1990;99:524–528. 27. Enander A, Stahle J. Hearing in Meniere’s disease. A study of pure-tone audiograms in 334 patients. Acta Otolaryngol 1967;64:543–546.

4. Claes J, Van de Heyning PH. A review of medical treatment for Meniere’s disease. Acta Otolaryngol 2000;544:34–39. 5. Konrad HR. Intractable vertigo—when not to operate. Otolaryngol Head Neck Surg 1986;95:482–484. 6. Coelho DH, Lalwani AK. Medical management of Meniere’s disease. Laryngoscope 2008;118:1099–1106. 7. Blakley BW. Update on intratympanic gentamicin for Meniere’s disease. Laryngoscope 2000;110:236–239. 8. Bodmer D, Morong S, Stewart C, et al. Long term vertigo control in patients after intatympanic gentamicin instillation for Meniere’s dis- ease. Otol Neurotol 2007;28:1140–1144. 9. Chia SH, Gamst AC, Anderson JP, et al. Intratympanic gentamicin ther- apy for Meniere’s disease: a meta-analysis. Otol Neurotol 2004;25:544– 552. 10. Cohen-Kerem R, Kislevsky V, Einarson TR, et al. Intratympanic gentami- cin for Meniere’s disease: a meta-analysis. Laryngoscope 2004;114:2085– 2091. 11. Perez N, Martin E, Garcia-Taipa R. Intratympanic gentamicin for intracta- ble Meniere’s disease. Laryngoscope 2003;113:456–464. 12. Kaplan DM, Nedzelski JM, Chen JM, et al. Intratympanic gentamicin for the treatment of unilateral Meniere’s disease. Laryngoscope 2000;110: 1298–1305. 13. De La Cruz A, Teufert KB, Berliner KI. Transmastoid labyrinthectomy versus translabyrinthine vestibular nerve section: does cutting the ves- tibular nerve make a difference in outcome? Otol Neurotol 2007;28:801– 808. 14. Crane BT, Minor LB, Della Santina CC, et al. Middle ear exploration in patients with Meniere’s disease who have failed outpatient intratym- panic gentamicin therapy. Otol Neurotol 2009;30:619–624. 15. Committee on Hearing and Equilibrium. Committee on Hearing and Equi- librium Guidelines for the diagnosis and evaluation of treatment of ther- apy in Meniere’s Disease. Otolaryngol Head Neck Surg 1995;113:181–185.

Laryngoscope 125: April 2015

Rah et al.: Intractable Menie` re’s Disease

53